IL6 and neoplasm: In contrast, iCAFs exhibit a secretory phenotype, producing high levels of inflammatory cytokines such as interleukin‐6 (IL‐6) and IL‐8, thereby modulating immune cell recruitment and tumor‐associated inflammation [13, 14].